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Introduction: Abnormal Immunoglobulin (Ig) levels have often been described in
cystic ﬁbrosis (CF) patients. The aim of the present study was to assess Ig levels
among our CF patients and relate them to parameters of disease severity.
Methods: IgG, IgA and IgM levels were measured in 73 CF patients with stable
disease at their year review. Hyper- and hypo-IgG patients were compared with
age- and sex-matched control patients who had normal IgG levels.
Results: Median age of patients was 15.2 years (0.3–24.5). Male/female ratio was
1:1. Chronic Pseudomonas aeruginosa infection was found in 54.8% of the patients,
while mean FEV1 was 86.6%. Two female patients aged 4.8 and 5.6 years had
hypo-IgG (2.73%). No difference was found in any parameters of disease severity
between hypo-IgG and control patients. Eight patients (75% of them females) with a
mean age: 14.7 years, had hyper-IgG (10.9%). Hyper-IgG patients had lower FEV1
(55.7% versus 84.3%, p< 0.005) and worse Shwachman scores (54.2 versus 82.6,
p< 0.005).
Conclusions: Hyper-IgG is a marker of worse clinical status among CF children,
could be explained by an increased inﬂammatory reaction and may be a useful tool
for monitoring CF paediatric patients.
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Background: Since the early 90’s, macrolides have been used in the treatment
of cystic ﬁbrosis (CF) patients because of their anti-inﬂammatory effects in
other diseases. Nevertheless, these effects in CF patients are controversy and the
molecular mechanisms remain unclear.
Objective: The aim of this study was to explore the effect of macrolides:
azithromycin (AZM), clarithromycin (CAM), erythromycin (EM) and josamycin
(JOSA) on molecular mechanisms of inﬂammation in CF.
Methods: Two CF bronchial epithelial cell lines (IB3−1 and CFBE41o-) and two
non-CF bronchial epithelial cell lines (S9 and 16HBE14o-) were pre-treated 30
minutes with the macrolide (10mg/ml) and the inductor (IL-1b or TNFa – 10 ng/ml)
was added for additional 16 h. IL-8 concentrations were evaluated in culture
supernatants by ELISA and multiplex assays directed against phosphoproteins were
performed on total protein extracts. NF-úB pathway was also investigated by a
p65-luciferase plasmid at 2 and 4 h of treatment.
Results: AZM was only able to signiﬁcantly reduce TNFa-induced IL-8 secretion in
S9 cells. CAM decreased IL-1b-induced IL-8 secretion in 16HBE14o- but increased
TNFa-induced IL-8 secretion in CFBE41o-. Moreover, JOSA decreased TNFa-
induced IL-8 secretion in both IB3−1 and S9 cells.
Multiplex assays showed us that AZM and TNF-a treatment increased phospho(p)-
ERK, p-STAT6, p-CREB and p-p65, compared to TNFa alone. After 2 h and 4 h
treatment, AZM and TNFa decreased NF-úB dependent-transcriptional activity in
S9 but not in IB3−1 cells treated only by TNFa.
Conclusion: Our study demonstrates that macrolides are not able to decrease
inﬂammation on CF bronchial epithelial cells.
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Pseudomonas aeruginosa is the prime cause of chronic infection, a key factor in
the destructive lung disease that occurs in CF patients. Toll-like receptors (TLRs)
are important for the recognition of pathogens and the induction of an innate
immune response. We previously demonstrated that mice deﬁcient in TLR2 and
TLR4 (TLR2/4−/−) were not hypersusceptible to lung infection by a wild-type
P. aeruginosa strain. In this study, we examined which components of the TLR
system are the most important for an innate lung response to this bacterium. We
found that TLR2/4−/− mice are hypersusceptible to infection by a P. aeruginosa
mutant unable to produce ﬂagellin. Infected mice show low amounts of TNF, IL-6,
KC and G-CSF, do not mobilize neutrophils and fail to control bacterial replication
in the lung. By contrast, administration of the same P. aeruginosa mutant to wild-
type mice triggers a protective innate response comparable to that induced by the
wild-type P. aeruginosa strain. We further demonstrated that hypersusceptibility is
due to the combined effects of the TLR4 mutation and the absence of ﬂagellin in
the bacterium, implicating TLR4 and TLR5. Further evidence was obtained that
lack of recognition of ﬂagellin is important as the intrapulmonary administration of
ﬂagellin following infection by the P. aeruginosa mutant, saved 100% of TLR4−/−
mice from death. We conclude that either TLR4 or TLR 5 can effectively defend
the lung from P. aeruginosa infection and the absence of a response by both pattern
recognition receptors results in hypersusceptibility to this infection.
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Background: Chronic Pseudomonas aeruginosa lung infection is characterized by
bioﬁlms surrounded by numerous PMNs in the lungs. Steep gradients of O2 are
present in the mucopurulent material in ventilated parts of chronically infected CF
lungs suggesting ongoing O2 consumption. We have evaluated the respiratory burst
of the PMNs as a cause of O2 depletion.
Methods: We have estimated the O2 concentration and the ROS production during
phagocytosis of P. aeruginosa (PAO1) by human PMNs. The respiratory burst and
the aerobe respiration was exposed by inhibition with KCN and DPI respectively.
The relevance of these in vitro ﬁndings was evaluated in freshly obtained sputum
from 17 chronically infected CF patients.
Results: In vitro: Addition of PAO1 to the PMNs resulted in the fastest reduction of
O2 to the level of detection (0.01mg/l) (p< 0.009). During the initial 30min 85%
(SD: 12%) of the O2 was consumed. The respiratory burst consumed the major part
of the O2 (p< 0.003) as shown by inhibition with DPI or KCN. ROS production
was almost completely inhibited with DPI, but was increased by KCN (p< 0.05).
In CF sputum: The O2 consumption was more varied during the initial 30min
(mean: 53%, SD: 35%). However, the O2 consumption was correlated to the
concentration of PMNs (p< 0.04, r2: 0.45) and the respiratory burst caused 52%
(SD: 26%) of the total O2 consumption.
Conclusion: The respiratory burst of the PMNs accelerates O2 consumption during
the interaction between PMNs and P. aeruginosa both in vitro and in CF sputum.
